Literature DB >> 9107386

Photodynamic inactivation of enveloped viruses by buckminsterfullerene.

F Käsermann1, C Kempf.   

Abstract

Photodynamic reactions induced by singlet oxygen-generating agents are known to inactivate enveloped viruses. In this report we demonstrate that the water-insoluble photosensitizer buckminsterfullerene (C60) can be used to mediate the inactivation of enveloped viruses. Viruses from two different families, Semliki Forest virus (SFV, Togaviridae) and vesicular stomatitis virus (VSV, Rhabdoviridae) were used as model systems. Buffered solutions containing C60 plus either of these viruses were illuminated with visible light for up to 5 h, resulting in a loss of infectivity of more than 7 log10/ml (TCID50). Furthermore, it was demonstrated that this viral inactivation was oxygen-dependent and equally efficient in solutions containing protein. C60 yields singlet oxygen in very high amounts and is completely inert to photo-oxidative destruction. In addition, it can be easily removed and recycled from aqueous solutions. For these reasons, it may prove useful in the inactivation of viruses in biological systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9107386     DOI: 10.1016/s0166-3542(96)01207-7

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  24 in total

1.  Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.

Authors:  Eleonora Reginato; Peter Wolf; Michael R Hamblin
Journal:  World J Immunol       Date:  2014-03-27

2.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

3.  Photodynamic therapy with fullerenes in vivo: reality or a dream?

Authors:  Sulbha K Sharma; Long Y Chiang; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2011-12       Impact factor: 5.307

4.  Nanoparticles: Emerging carriers for drug delivery.

Authors:  Sagar R Mudshinge; Amol B Deore; Sachin Patil; Chetan M Bhalgat
Journal:  Saudi Pharm J       Date:  2011-04-21       Impact factor: 4.330

5.  Advances in antimicrobial photodynamic inactivation at the nanoscale.

Authors:  Nasim Kashef; Ying-Ying Huang; Michael R Hamblin
Journal:  Nanophotonics       Date:  2017-08-01       Impact factor: 8.449

6.  Cationic fullerenes are effective and selective antimicrobial photosensitizers.

Authors:  George P Tegos; Tatiana N Demidova; Dennisse Arcila-Lopez; Haeryeon Lee; Tim Wharton; Hariprasad Gali; Michael R Hamblin
Journal:  Chem Biol       Date:  2005-10

Review 7.  Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond.

Authors:  Rui Yin; Tianhong Dai; Pinar Avci; Ana Elisa Serafim Jorge; Wanessa C M A de Melo; Daniela Vecchio; Ying-Ying Huang; Asheesh Gupta; Michael R Hamblin
Journal:  Curr Opin Pharmacol       Date:  2013-09-20       Impact factor: 5.547

Review 8.  Photodynamic therapy with fullerenes.

Authors:  Pawel Mroz; George P Tegos; Hariprasad Gali; Tim Wharton; Tadeusz Sarna; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2007-10-08       Impact factor: 3.982

9.  Comparative toxicity of C60 aggregates toward mammalian cells: role of tetrahydrofuran (THF) decomposition.

Authors:  Michael Kovochich; Benjamin Espinasse; Melanie Auffan; Ernest M Hotze; Lauren Wessel; Tian Xia; Andre E Nel; Mark R Wiesner
Journal:  Environ Sci Technol       Date:  2009-08-15       Impact factor: 9.028

Review 10.  Medicinal applications of fullerenes.

Authors:  Rania Bakry; Rainer M Vallant; Muhammad Najam-ul-Haq; Matthias Rainer; Zoltan Szabo; Christian W Huck; Günther K Bonn
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.